FDA warns Novo Nordisk over unreported potential Ozempic side effects
Novo Nordisk, the pharmaceutical company behind Ozempic, has received a warning letter from the U.S. Food and Drug…
The era of $199 copycat weight loss drugs is ending — and it could cost patients
After two splashy Super Bowl commercials focused on making weight loss medication more accessible, Hims & Hers will…
Has anyone died from taking GLP-1 weight-loss drugs? – Baltimore Sun
Has anyone died from taking GLP-1 weight-loss drugs? Baltimore SunPAHO calls for strengthened pharmacovigilance following reports of misuse of…
Ozempic, Wegovy list prices to be slashed by up to 50%
Weight loss drugmaker Novo Nordisk will cut the list prices of Ozempic and Wegovy by up to 50%…
1 Reason Why I’d Hold This Weight‑Loss Drug Leader Through Any Market Crash
Novo Nordisk (NYSE: NVO) and Eli Lilly (NYSE: LLY) are locked in a battle around GLP-1 weight-loss drugs.…
NHS must keep medicine rebate down or lose investment
Wednesday 18 February 2026 2:27 pm | Updated: Wednesday 18 February 2026 3:10 pm Share Facebook Share on Facebook…
Dr Reddy’s says Wegovy copycat to be priced competitively, with 50-60pc discounts feasible
HYDERABAD, Feb 18 — Indian drugmaker Dr Reddy’s Laboratories hopes to launch a generic version of Novo Nordisk’s…
Novo Nordisk plans Wegovy vials amid obesity-drug competition
Novo Nordisk plans Wegovy vials amid obesity-drug competition Proactive uses images sourced from Shutterstock Novo Nordisk (NYSE:NVO) announced…
Wegovy maker sues rival over ‘knock-off’ weight-loss drugs
[Getty Images] The maker of Ozempic and Wegovy is suing a rival firm for selling what it says…
The most controversial Super Bowl ad of 2025 is back for more
Super Bowl Sunday is the holy grail of advertising thanks to its massive viewership, with an average of…
Hims launches $49 compounded copy of Wegovy weight-loss pill
By Amina Niasse NEW YORK, Feb 5 (Reuters) – Online telehealth company Hims and Hers Health will start…
Hims and Hers Health’s compounded Wegovy pill offering fuels market jitters
Feb 5 (Reuters) – Hims & Hers said it would begin offering compounded versions of Novo Nordisk’s Wegovy…